Wikidata

(Q39740475)

English

Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis

scientific article

In more languages

Statements

title
Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasis (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
author name string
Pamela M Holland
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
Robert Miller
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
Jon Jones
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
Heather Douangpanya
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
Julia Piasecki
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
Martine Roudier
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
William C Dougall
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
publication date
1 April 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017
page(s)
539-550
1 reference
stated in
Europe PubMed Central
PubMed ID
20150760
retrieved
14 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39740475&oldid=2089244393"